SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant volatility and community debate after pulling its compounded GLP-1 drug amid a patent infringement lawsuit from Novo Nordisk and increased regulatory scrutiny. Investors are sharply divided between calls for a short squeeze and a rebound from oversold levels, and predictions of further downside due to ongoing legal and business model challenges.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending due to its all-stock acquisition of Valaris (VAL), a strategic consolidation that the community largely views as enhancing its market leadership and pricing power in an anticipated offshore drilling upcycle, though some express concerns over share dilution.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies ($PGY) is trending due to a significant market sell-off following its Q4 earnings, where conservative guidance for the coming year overshadowed stronger-than-expected profitability. The community is debating whether this reflects an extreme overreaction to management's focus on prudent risk management or a deeper concern within the AI-powered fintech sector.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is currently trending after its stock dramatically dropped following news of an SEC review into its accounting practices, reduced guidance, and the departure of its CFO and General Counsel. The community is sharply divided, with some calling it an extreme "overreaction" and a unique "buy-the-dip" opportunity, while others express severe concerns about potential financial improprieties, urging investors to "stay away" until more clarity emerges.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as the community discusses its strategic acquisition of StereoLabs, which creates a unified lidar and camera platform for Physical AI applications. This move is largely seen as strengthening Ouster's market leadership and accelerating its path to profitability through StereoLabs' EBITDA-positive business.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending following a puzzling stock dip, which occurred despite strong earnings and raised guidance, prompting community discussion about whether an overreaction to its Super Bowl commercial or broader market sentiment is creating a 'buying opportunity'.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is experiencing a sharp sell-off after issuing a weaker-than-expected revenue outlook and withdrawing its long-term targets, intensifying broader market fears about AI disruption to the traditional software sector. Despite beating Q4 earnings, the community is divided between those viewing the steep decline as an overreaction and a buying opportunity, and others who believe AI poses a fundamental threat to the SaaS business model.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending as its Eversense 365 one-year implantable CGM recently received European CE Mark approval and integrated with the twiist automated insulin delivery system, signaling potential for expanded market access. While the community highlights the product's superior technology and opportunities from competitor issues, many investors express mixed sentiment due to concerns over management's commercial execution and historical stock performance.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

REGENXBIO is trending due to intense community speculation surrounding an imminent FDA decision on its RGX-121 gene therapy for Hunter Syndrome, as a recent clinical hold on the program and a related therapy, stemming from a serious adverse event, has many anticipating a Complete Response Letter or a regulatory delay.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as the community eagerly discusses the recently inaugurated Eagle Line pilot production facility, seen as a pivotal move towards scalable solid-state battery manufacturing and potential new OEM partnerships. Many anticipate its upcoming earnings report will provide crucial commercialization details, potentially fueling a significant market re-rate from current levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Kyndryl Holdings, Inc. (Kyndryl or the Company) (NYSE: KD) investors concerning the Companys possible violations of federal...

Securities Fraud Investigation Into Kyndryl Holdings, Inc. (KD) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Kyndryl Holdings, Inc. (Kyndryl or the Company) (NYSE: KD) on behalf of investors concerning the Companys possible violations of federal...

KD INVESTIGATION ALERT: Kyndryl Holdings, Inc. is being Investigated for Securities Fraud by BFA Law after Accounting Review and CFO Exit Lead to 53% Stock Drop

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Kyndryl Holdings, Inc. (NYSE:KD) for potential violations of the federal securities laws. If you invested in...

<ul class="summary-bullets"><li>Kyndryl Holdings stated that its audit committee is reviewing cash management, disclosures, and internal financial controls, following voluntary document requests from the SEC.</li><li>The firm expects to report material weaknesses in internal financial controls for the upcoming quarter, fiscal 2025, and the first two quarters of fiscal 2026.</li><li>It expects fiscal 2026 adjusted pretax income between $575 million and $600 million, below an earlier guidance of at least $725 million.</li></ul>Kyndryl Holdings Inc (KD) stock plummeted 55% on Monday to its lowest level in over three years, after the company reported a series of updates, including the departure of its CFO and delays in certain regulatory filings, alongside a lowered financial guidance for fiscal 2026.Trading in the stock was halted twice after the opening bell.<h2 class="st-heading-2">CFO Departs Amid Audit Committee Review</h2>Kyndryl said David Wyshner has stepped down as CFO and Edward Sebold has left his role as general counsel, both effective immediately. Wyshner has been replaced by Harsh Chugh, who has been named as interim CFO. Mark Ringes has been named Interim General Counsel.In a separate release, the company said that its Audit Committee is reviewing cash management, disclosures, and internal financial controls, following voluntary document requests from the Division of Enforcement of the Securities and Exchange Commission (SEC). As a result, Kyndryl said it needs more time to complete its evaluation, which will delay the filing of its Form 10-Q.Kyndryl said it expects to report material weaknesses in its internal control over financial reporting in the upcoming quarterly report, as well as for fiscal year 2025 and the first two quarters of fiscal 2026.<h2 class="st-heading-2">Kyndryl&nbsp;Cuts FY2026 Earnings Guidance</h2>Kyndryl expects fiscal 2026 adjusted pretax income between $575 million and $600 million, significantly below its previous guidance of at least $725 million. The company also cut its earnings before interest, tax, depreciation, and amortization (EBITDA) margin to 17.5% from 18%. The company now expects a 2% to 3% decline in constant-currency revenue, compared to 1% growth it had forecast earlier.While third-quarter (Q3) revenue came in at $3.86 billion, marginally below Wall Street’s $3.89 billion estimate, according to Fiscal.ai data, its earnings of $0.25 per share were less than half the Street's $0.67 per share estimate.Oppenheimer downgraded Kyndryl to “Perform” from “Outperform” and removed its prior price target, according to The Fly. Analyst Ian Zaffino added that Wyshner’s departure creates uncertainty.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday slump, retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘extremely high’ message volumes. <a href="https://stocktwits.com/symbol/KD">KD</a> was among the top trending tickers at the time of writing.<img src="https://news.stocktwits-cdn.com/KD_jpg_d5653784f9.webp" alt="KD.jpg">One user noted the company’s positive cash flow and called the selloff a “huge overreaction.”<stembedurl>https://stocktwits.com/tothattila/message/644440704</stembedurl>The stock has shed more than 60% of its value so far in 2026.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-vzla-stock-slump-today/cZbv2wsR4oQ">Vizsla Silver Issues Update On Abducted Employees In Mexico – VZLA Stock Down 14%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Information technology infrastructure provider Kyndryl (USA) booth at Tokyo Rainbow Parade 2023. (Photo by Stanislav Kogiku/SOPA Images/LightRocket via Getty Images)

KD Stock Sinks 55% To Over 3-Year Lows – What Triggered This Selloff?

The company announced the departure of its CFO, delays in certain regulatory filings, and a lowered fiscal 2026 outlook.

Equity

Kyndryl Q3 Earnings Call Highlights

Kyndryl (NYSE:KD) reported third-quarter fiscal 2026 results that management said reflected margin expansion, higher earnings, and positive free cash flow, even as longer sales cycles and changes in...

Kyndryl (NYSE:KD) Given Market Perform Rating at Oppenheimer

Oppenheimer reiterated a "market perform" rating on shares of Kyndryl in a research note on Monday...

Kyndryl (NYSE:KD) Shares Gap Down After Earnings Miss

Kyndryl (NYSE:KD) Shares Gap Down on Disappointing Earnings...

Kyndryl (NYSE:KD) Stock Rating Lowered by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered shares of Kyndryl from an "overweight" rating to an "underweight" rating and set a $16.00 price objective for the company. in a research note on Monday...

Kyndryl Holdings Stock Tanks 50% Over Decline In Q3 Earnings

(RTTNews) - Shares of Kyndryl Holdings, Inc. (KD) are tumbling about 52 percent on Monday morning trading following announcement of its third-quarter financial results, which saw a sharp decline in...

Kyndryl Holdings, Inc. (KD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Kyndryl Holdings, Inc. (KD) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

$KD Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.25 down -73.12% YoY
• Reported revenue of $3.86B up 3.07% YoY
• Kyndryl expects fiscal 2026 adjusted pretax income of $575M, adjusted EBITDA margin of approximately 17.5%, and free cash flow of $325M, while constant-currency revenue is projected to decline 2% to 3%.

Stocktwits

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.25 down -73.12% YoY
• Reported revenue of $3.86B up 3.07% YoY
• Kyndryl expects fiscal 2026 adjusted pretax income of $575M, adjusted EBITDA margin of approximately 17.5%, and free cash flow of $325M, while constant-currency revenue is projected to decline 2% to 3%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Robinhood Markets Inc

Stocktwits Polls

An ongoing SEC inquiry into cash management and accounting practices, along with the abrupt departures of the CFO and General Counsel, has ignited serious governance concerns.

The stock plunged over 55% to a 3-year low following weak Q3 results, lowered FY26 guidance, and renewed governance concerns.

Many traders view the dramatic decline as an overreaction, actively buying the dip and anticipating a swift bounce back to the $12-$15 range.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	--	$0.52	--	N/A
Q3 '26	--	$0.52	--	N/A
Q2 '26	--	$0.38	--	N/A
Q1 '26	$0.83	$0.37	-55.42%	MISSED
Q3 '25	$0.60	$0.52	-13.90%	MISSED

KD
Kyndryl Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '26

Historical Earnings

Latest KD News

KDKyndryl Holdings Inc